Raphael Pharmaceutical
Research programs
Pipeline snapshot
A status-led view of the research platform.
Each program is described with the evidence that exists today. The presentation intentionally avoids unsupported clinical phases, regulatory commitments and timelines.
Rheumatoid arthritisLead program · proof-of-concept research completedDocumented clinical proof-of-concept research; further study plans are not confirmed trial commitments.View program
Autoimmune & inflammatory researchResearch platform / historical recordLegacy materials describe CBX, immune-cell communication and chronic-inflammation research; the current page does not imply an active program.View record
Oncology supportive careHistorical / exploratory contextLegacy materials describe supportive-care research context, not anticancer efficacy or a confirmed current partnership.View record
Personalized cannabinoid researchResearch hypothesisLegacy materials describe receptor mapping in biopsies and cells; this is not a prescription or treatment service.View record